Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.00
Bid: 349.00
Ask: 361.00
Change: 1.00 (0.28%)
Spread: 12.00 (3.438%)
Open: 362.00
High: 362.00
Low: 362.00
Prev. Close: 361.00
WIL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Jan 2019 07:00

RNS Number : 1910N
Wilmington PLC
16 January 2019
 

16 January 2019

Wilmington plc

("Wilmington" or the "Company" or "Group")

Directorate Change

 

Wilmington plc (LSE: WIL), the provider of information, education and networking services in Risk & Compliance, Professional and Healthcare knowledge areas, announces that Pedro Ros has informed the Board of his intention to step down from his position as Chief Executive Officer of the Company. The Board has agreed with Pedro that he will step down from the Board on 13 February 2019 and will be available over the following months to ensure a smooth and orderly handover.

 

Martin Morgan, Chairman, will act as Executive Chairman from 13 February until Pedro's replacement is appointed. The Board will initiate a search for a new Chief Executive Officer and an update will be made in due course.

 

As previously advised, the Company will announce its half year results for the period to 31 December 2018 on Thursday 21 February 2019.

 

Martin Morgan, Chairman, commented:

 

"I would like to thank Pedro for his dedication and contribution to Wilmington over the last five years. Since joining Wilmington in 2014, Pedro has executed a significant change programme and focused on building our key market sectors in Risk & Compliance, Professional and Healthcare. During Pedro's tenure, Wilmington has also begun the important process of modernising its infrastructure which includes the implementation of common technologies, especially in the areas of customer relationship management, digital learning and marketing. The Company has many opportunities for renewed growth and, on behalf of the Board and employees of Wilmington, we wish Pedro all the best in his future endeavours."

 

Pedro Ros, Chief Executive Officer, said: 

 

"During the last five years, Wilmington has completed a major transformation and I believe that now is the right time to hand over to my successor. I am proud of our many achievements during that time and I thank our people and the Board for their continuous support. I look forward to working with Martin to ensure a smooth transition."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 592/2014. Upon the publication of this announcement via a Regulatory Information Service this inside information is now considered to be in the public domain.

 

For further information, please contact:

Wilmington plc

Martin Morgan, Chairman

Richard Amos, Chief Financial Officer

 

FTI Consulting

Charles Palmer / Dwight Burden / Leah Dudley

 

020 7490 0049

 

 

 

020 3727 1000

 

 

 

Notes to Editors

Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and operates in 120 countries. Wilmington plc is a premium listed company on the main market of the London Stock Exchange.

 

-End-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOACKPDDFBKDQDD
Date   Source Headline
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company
20th Feb 20237:00 amRNSHalf-year Report
9th Feb 202312:36 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSNotice of Half Year-End Results
19th Dec 202211:32 amRNSHolding(s) in Company
12th Dec 20227:00 amRNSJoint Broker appointment
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:50 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
23rd Nov 20223:12 pmRNSResult of AGM
15th Nov 20222:31 pmRNSHolding(s) in Company
17th Oct 202212:11 pmRNSHoling(s) in Company
17th Oct 202212:11 pmRNSHolding(s) in Company
3rd Oct 20225:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20224:42 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
29th Sep 20223:43 pmRNSHolding(s) in Company
29th Sep 20223:36 pmRNSIssue of ordinary shares
22nd Sep 20227:00 amRNSFinancial results for the year ended 30 June 2022
31st Aug 20227:00 amRNSNotice of Results
19th Aug 20225:07 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSYear-End Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights
29th Jun 20223:04 pmRNSHolding(s) in Company
14th Jun 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.